CA
NZ
UK
AU
IND
US
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5% of Quest Diagnostics Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,901,240 shares of common stock in Realloys Inc, representing 5.7% of the class, as of a triggering event dated September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 30,001,137 shares of Recursion Pharmaceuticals Inc. common stock as of September 30, 2026.
Stratasys Ltd. filed a Form 6-K on November 10, 2026, reporting the results of its 2026 annual general meeting of shareholders, at which shareholders approved the re-election or initial election of eight directors and the re-appointment of its independent auditors.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 41,513,057 shares of ONEOK Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a beneficial ownership position in Park Aerospace Corp common stock as of September 30, 2026.
State Street Corporation and SSGA Funds Management, Inc. filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership positions in Peabody Energy Corp as of September 30, 2026.
HeartSciences Inc. filed Definitive Additional Materials on November 10, 2026, supplementing its October 19, 2026 proxy statement with updated information on the board composition and director biographies for the combined company expected to result from its pending merger with Fortitude Mining Holdings, Inc.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,026,991 shares of common stock in Perspective Therapeutics Inc as of September 30, 2026.
Nika Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing continued operating losses, no revenue, and a total stockholders' deficit of $343,705.
Please wait processing your request...